America’s drug-price strategy could hit Swiss health-insurance premiums
- Words
- 56
- Chars
- 352
- AI summary
- Yes
A new study calculates that measures aimed at lowering drug prices in the United States could add hundreds of millions of Swiss francs to health‑insurance premiums each year. Switzerland already ranks among the countries with the highest medication costs, while American prices are even higher. The U.S. government is pushing pharmaceutical firms to reduce charges for new medicines. Companies such as the Swiss giant Roche are among those expected to adjust pricing. The projected premium increase stems from cross‑border effects of the American policy.
Efforts to cut American drug prices could cost Swiss health-insurance premium payers hundreds of millions of francs a year, a new study finds. Drug prices in Switzerland are among the world’s highest. In America, they are higher still. The American government wants pharmaceutical companies to charge less for new medicines. For firms such as Roche […]
Open article